2014 Guideline for NSTE-ACS Management Has New Name, Focus - TCTMD.com
The recently released American College of Cardiology (ACC)/American Heart Association (AHA) 2014 Guideline for the Management of Patients with Non–ST-Elevation Acute Coronary Syndromes (NSTE-ACS) features a title change from the previous version as well as recognition of an alternate strategy for low-risk patients and the importance of ongoing postdischarge care.
Another update reflects evidence for the superior efficacy of newer antiplatelet agents. Ongoing P2Y12 inhibitor therapy is recommended for all NSTE-ACS patients irrespective of the initial treatment approach. But for the first time, said co-author Debabrata Mukherjee, MD, of Texas Tech University Health Sciences Center (El Paso, TX), in an email with TCTMD, the guidelines say choice of the more potent agent ticagrelor over clopidogrel is reasonable, as is use of prasugrel in stented patients who are not at high bleeding risk.
Read the full story >>
TTUHSC Celebration of Life Service was held March 25th in remembrance of Tom McGovern, Ed.D.
TTUHSC has been named as a Military Friendly® School for 2022-2023. Among graduate schools, TTUHSC ranked fourth in the nation, achieving Gold award status.
On March 16, fourth-year TTUHSC Jerry H. Hodge School of Pharmacy students interested in completing a residency after they graduate in May, learned where they would spend the next stage of their training during the Pharmacy Residency Match Day.
CPRIT recently awarded a $1 million prevention grant to Rakhshanda Rahman, M.D., Rebeccah Baucom, M.D., and John Kidwell, M.D., from the TTUHSC School of Medicine.
The Innovation Hub at Research Park today (September 26, 2022) announced the winners of its annual Presidents' Innovative Startup Awards. The award recognizes startups that have a high potential for growth and an economic impact in West Texas.